TP53 and neoplasm: A single chain variable fragment (scFv) from one such antibody, 3E10, can facilitate cell entry of therapeutic proteins and has been used to construct bispecific antibodies targeting cancer cell growth by enhancing p53 tumor suppressor function [25].